The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Sporadic Pick's disease: A tauopathy characterized by a spectrum of pathological τ isoforms in gray and white matter
Abstract
Pick's disease is characterized neuropathologically by distinct τ‐immunoreactive intraneuronal inclusions known as Pick bodies and by insoluble τ proteins with predominantly three microtubule‐binding repeat τ isoforms. However, recent immunohistochemical studies showed that the antibody specific for exon 10, which encodes the fourth microtubule‐binding repeat, detected other τ lesions in Pick's disease. To better define the spectrum of τ pathology in Pick's disease, we used biochemical, immunohistochemical, and ultrastructural techniques to analyze the τ isoform composition in 14 Pick's disease brains. Western blot analysis showed that both three and four microtubule‐binding repeat pathological τ isoforms are present in gray and white matter of various brain regions. Using phosphorylation‐dependent anti‐τ antibodies, we show that major τ phosphoepitopes are present in sarcosyl‐insoluble gray and white matter regions of Pick's disease brains. Also, for the first time to our knowledge, we demonstrated that isoforms with four microtubule‐binding repeat τ isoforms are present in Pick bodies from selected brains. Isolated τ filaments were straight or twisted and formed by three microtubule‐binding repeat or four microtubule‐binding repeat τ isoforms. Major τ phosphorylation–dependent and exon 10–specific epitopes were present in filaments. Therefore, Pick's disease is characterized by an accumulations of Pick bodies in the hippocampal region and cortex as well as the presence of three and four microtubule‐binding repeat τ pathology in both cortical gray and white matter that distinguish this tauopathy from other neurodegenerative disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NFTs in AD contain a mixture of 4R-Tau and 3R-Tau1, while deposits in progressive supranuclear palsy predominantly contain 4R-Tau15, and Pick’s disease inclusions mostly have 3R-Tau16.”
From Liquid–liquid phase separation of the microtubule-binding repeats of the Alzheimer-related protein Tau (2017) · cites this paper as [16]
Citations
Cites
A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418 · cited 2×
“Soluble and sarcosyl-insoluble was purified from cortical gray and adjacent white matter separately as described.(18,27) Samples were resolved on 7.”
MethodSelf-citationLewis, J., McGowan, E., Rockwood, J., Melrose, H., Nacharaju, P., Van Slegtenhorst, M., Gwinn-Hardy, K., Murphy, M. P., Baker, M., Yu, X., et al. (2000) · Nature Genetics · doi:10.1038/78078 · Cited by 1,371
Bramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., & Lee, V. M. Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90057-x · Cited by 903
Self-citationMIRRA, S. S., GEARING, M., MCKEEL, D. W., CRAIN, B. J., HUGHES, J. P., BELLE, G. V., & HEYMAN, A. (1994) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199405000-00012 · Cited by 156
Cognitive, neuroimaging, and pathological studies in a patient with Pick's disease
Lieberman, A. P., Trojanowski, J. Q., Lee, V. M. ‐., Balin, B. J., Ding, X., Greenberg, J., Morrison, D., Reivich, M., & Grossman, M. (1998) · Annals of Neurology · doi:10.1002/ana.410430218 · Cited by 54
Self-citation
Research works printed but not linked: 37
- 10.1002/ana.410400204 · DOI · Paper page
- Yoshimura N, 1989, Topography of Pick body distribution in Pick's disease: a contribution to understanding the relationship between Pick's and Alzheimer's diseases, Clin Neuropathol, 8, 1
- 10.1097/00005072-199601000-00010 · DOI · Paper page
- 10.1159/000114320 · DOI · Paper page
- 10.1111/j.1750-3639.1998.tb00158.x · DOI · Paper page
- 10.1007/s004010050565 · DOI · Paper page
- 10.1007/BF00296179 · DOI
- 10.1007/s004010051051 · DOI
- 10.1001/archneur.1997.00550230088023 · DOI
- 10.1001/archneur.1997.00550230090024 · DOI
- Trojanowski JQT, 2001, Update on the neuropathological diagnosis of frontotemporal dementias, Ann Neurol, 60, 1123
- 10.1007/BF00690400 · doi:10.1007/bf00690400
- 10.1007/BF00334500 · DOI
- 10.1111/j.1365-2990.1989.tb01224.x · DOI
- 10.1002/ana.410270407 · DOI
- 10.1016/S0002-9440(10)64099-0 · DOI
- 10.1126/science.282.5395.1914 · DOI · Paper page
- 10.1097/00005072-199602000-00004 · DOI · Paper page
- 10.1002/ana.410430209 · DOI · Paper page
- 10.1007/s004019900177 · DOI
- 10.1007/s004010000283 · DOI · Paper page
- 10.1097/00005072-199605000-00001 · DOI · Paper page
- 10.1212/WNL.44.11.2015 · DOI · Paper page
- 10.1016/S0896-6273(00)81127-7 · DOI · Paper page
- 10.1016/0896-6273(92)90117-V · DOI · Paper page
- 10.1016/0197-4580(94)90140-6 · DOI
- 10.1007/BF00309625 · DOI
- 10.1016/0022-510X(87)90153-5 · doi:10.1016/0022-510x(87)90153-5
- 10.1007/s004010051014 · DOI
- Hansen LA, 1988, Neocortical morphometry and cholinergic neurochemistry in Pick's disease, Am J Pathol, 131, 507
- 10.1002/1531-8249(200012)48:6<859::AID-ANA6>3.0.CO;2-1 · doi:10.1002/1531-8249(200012)48:6<859::aid-ana6>3.0.co;2-1
- 10.1097/00005072-199912000-00002 · DOI · Paper page
- 10.1002/ana.1223 · DOI
- 10.1093/jnen/59.11.990 · DOI · Paper page
- 10.1002/1531-8249(200012)48:6<850::AID-ANA5>3.0.CO;2-V · doi:10.1002/1531-8249(200012)48:6<850::aid-ana5>3.0.co;2-v
- 10.1002/1531-8249(199906)45:6<704::AID-ANA4>3.0.CO;2-X · DOI
- 10.1093/neucas/7.1.31 · DOI
Cited by
Cairns, N. J., Bigio, E. H., Mackenzie, I. R. A., Neumann, M., Lee, V. M.-Y., Hatanpaa, K. J., White, C. L., Schneider, J. A., Grinberg, L. T., Halliday, G., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0237-2 · Cited by 1,110
Self-citationAmbadipudi, S., Biernat, J., Riedel, D., Mandelkow, E., & Zweckstetter, M. (2017) · Nature Communications · doi:10.1038/s41467-017-00480-0 · Cited by 782
Arendt, T., Stieler, J. T., & Holzer, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.08.018 · Cited by 609
Frontotemporal Lobar Degeneration: Epidemiology, Pathophysiology, Diagnosis and Management
Rabinovici, G. D., & Miller, B. L. (2010) · CNS Drugs · doi:10.2165/11533100-000000000-00000 · Cited by 501
Self-citationInvited review: Neuropathology of tauopathies: principles and practice
Kovacs, G. G. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12208 · Cited by 492
The importance of tau phosphorylation for neurodegenerative diseases
Noble, W., Hanger, D. P., Miller, C. C. J., & Lovestone, S. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00083 · Cited by 475
Olney, N. T., Spina, S., & Miller, B. L. (2017) · Neurologic Clinics · doi:10.1016/j.ncl.2017.01.008 · Cited by 419
Self-citationMackenzie, I. R. A., & Neumann, M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13588 · Cited by 381
Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau)
Dickson, D. W., Kouri, N., Murray, M. E., & Josephs, K. A. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9589-0 · Cited by 380
White matter damage in primary progressive aphasias: a diffusion tensor tractography study
Galantucci, S., Tartaglia, M. C., Wilson, S. M., Henry, M. L., Filippi, M., Agosta, F., Dronkers, N. F., Henry, R. G., Ogar, J. M., Miller, B. L., et al. (2011) · Brain · doi:10.1093/brain/awr099 · Cited by 306
Self-citationFrontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine
Irwin, D. J., Cairns, N. J., Grossman, M., McMillan, C. T., Lee, E. B., Van Deerlin, V. M., Lee, V. M.-Y., & Trojanowski, J. Q. (2015) · Acta Neuropathologica · doi:10.1007/s00401-014-1380-1 · Cited by 264
Self-citationBoluda, S., Iba, M., Zhang, B., Raible, K. M., Lee, V. M.-Y., & Trojanowski, J. Q. (2015) · Acta Neuropathologica · doi:10.1007/s00401-014-1373-0 · Cited by 263
Self-citationWilliams, D. R. (2006) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2006.01153.x · Cited by 259
Tau isoform regulation is region‐ and cell‐specific in mouse brain
McMillan, P., Korvatska, E., Poorkaj, P., Evstafjeva, Z., Robinson, L., Greenup, L., Leverenz, J., Schellenberg, G. D., & D'Souza, I. (2008) · Journal of Comparative Neurology · doi:10.1002/cne.21867 · Cited by 179
“…toward increased 4R (progressive supranuclear palsy [PSP]; Arai et al., 2001; Zhukareva et al., 2006; and corticobasal degeneration [CBD]; Fujino et al., 2005) or increased 3R-tau (Pick’s disease; Zhukareva et al., 2002) with distinct localization of aggregated tau structures for each disorder.”
BackgroundAnderson, J. M., Hampton, D. W., Patani, R., Pryce, G., Crowther, R. A., Reynolds, R., Franklin, R. J. M., Giovannoni, G., Compston, D. A. S., Baker, D., et al. (2008) · Brain · doi:10.1093/brain/awn119 · Cited by 141
“These same epitopes are known to be phosphorylated in degenerative tauopathies, characterized by a toxic gain of function and the formation of insoluble filamentous aggregates (Goedert et al., 1992; Forman et al., 2002; Zhukareva et al., 2002a, b; Goedert, 2004; Mott et al., 2005).”
Acetylated Tau Neuropathology in Sporadic and Hereditary Tauopathies
Irwin, D. J., Cohen, T. J., Grossman, M., Arnold, S. E., McCarty-Wood, E., Van Deerlin, V. M., Lee, V. M.-Y., & Trojanowski, J. Q. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.04.025 · Cited by 125
Self-citationDifferential Incorporation of Tau Isoforms in Alzheimer's Disease
Espinoza, M., de Silva, R., Dickson, D. W., & Davies, P. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-14101 · Cited by 119
Neuropathology of non-Alzheimer degenerative disorders.
(2009) · PubMed Central · Cited by 117
Zhang, Y., Tartaglia, M. C., Schuff, N., Chiang, G. C., Ching, C., Rosen, H. J., Gorno-Tempini, M. L., Miller, B. L., & Weiner, M. W. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-121156 · Cited by 94
Self-citationGibbons, G. S., Banks, R. A., Kim, B., Changolkar, L., Riddle, D. M., Leight, S. N., Irwin, D. J., Trojanowski, J. Q., & Lee, V. M. Y. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly010 · Cited by 94
“However, 12E8 turns out to be fixation-dependent and detected both 3R and 4R tau aggregates (37, 38).”
BackgroundSelf-citationTranscriptional and conformational changes of the tau molecule in Alzheimer's disease
Hyman, B. T., Augustinack, J. C., & Ingelsson, M. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.015 · Cited by 79
Quantitative analysis of tau isoform transcripts in sporadic tauopathies
Connell, J. W., Rodriguez-Martin, T., Gibb, G. M., Kahn, N. M., Grierson, A. J., Hanger, D. P., Revesz, T., Lantos, P. L., Anderton, B. H., & Gallo, J.-M. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.02.014 · Cited by 70
Miki, Y., Mori, F., Hori, E., Kaimori, M., & Wakabayashi, K. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0531-2 · Cited by 29
Dickson, D. W. (2007) · Blue Books of Neurology · doi:10.1016/s1877-184x(09)70058-9 · Cited by 3
Metadata
- Authors
- Zhukareva, V., Mann, D., Pickering‐Brown, S., Uryu, K., Shuck, T., Shah, K., Grossman, M., Miller, B. L., Hulette, C. M., Feinstein, S. C., Trojanowski, J. Q., & Lee, V. M. ‐.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2002-05-21
- Volume
- 51
- Issue
- 6
- Pages
- 730-739
- ISSN
- 0364-5134
- 1531-8249
- Cited by
- 133
- References
- 5
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.